Generalizability of Homeopathic Prognostic Factor Research Outcome in COVID-19 Treatment: Comparison of Data.
Background/Objective During the coronavirus disease 2019 (COVID-19) pandemic, several homeopathic prognostic factor research (PFR) projects have been undertaken. We found two projects with comparable outcomes to assess consistency and possible flaws. Methods Two comparisons were made. (1) Outcome...
| Publicado en: | Homeopathy Vol. 111; no. 3; pp. 157 - 164 |
|---|---|
| Autores principales: | , , , , , , , , , , , |
| Formato: | research tables/charts Journal Article |
| Publicado: |
Thieme Medical Publishing Inc.
2022
|
| Acceso en línea: | Ver este registro en EBSCOhost |
| fields | @attributes: recordID: 1 pdfLink: plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=158143549&site=ehost-live header: @attributes: shortDbName: ccm uiTerm: 158143549 longDbName: CINAHL Complete uiTag: AN controlInfo: bkinfo: dissinfo: jinfo: jid: 14754916 L6I jtl: Homeopathy issn: 14754916 maglogo: N pubinfo: dt: 2022 vid: 111 iid: 3 pid: 2811 pub: Thieme Medical Publishing Inc. place: New York, New York artinfo: ui: 158143549 158143549 158143549 10.1055/s-0041-1732307 158143549 ppf: 157 ppct: 7 formats: tig: atl: Generalizability of Homeopathic Prognostic Factor Research Outcome in COVID-19 Treatment: Comparison of Data. aug: au: Rutten, Lex Miglani, Anjali Gold, Peter Manchanda, Raj Kumar Chakraborty, Moumita Meena, Baljeet Singh Sharma, Kavita Gupta, Meeta Sharma, Brender Sharma, Ashok Rani, Purnima Singh, Rahul Kumar affil: Aard 10, 4813NN Breda, The Netherlands sug: subj: COVID-19 Prognosis Homeopathy Research, Alternative Therapies COVID-19 Drug Therapy Homeopathic Agents Therapeutic Use Antiviral Agents Therapeutic Use Drug Efficacy Evaluation Human Comparative Studies Descriptive Statistics Consensus Physicians India Databases, Health COVID-19 Symptoms Confidence Intervals Dyspnea Drug Therapy Headache Shivering Pharyngitis Drug Therapy Muscle Pain Drug Therapy Prescribing Patterns Homeopathic Agents Administration and Dosage ab: Background/Objective During the coronavirus disease 2019 (COVID-19) pandemic, several homeopathic prognostic factor research (PFR) projects have been undertaken. We found two projects with comparable outcomes to assess consistency and possible flaws. Methods Two comparisons were made. (1) Outcome of a PFR data collection from the Liga Medicorum Homoeopathica Internationalis (LMHI) by about 100 doctors with 541 cases was compared with a previous analysis of 161 cases in the same database. (2) The updated LMHI database was also compared with a data collection carried out in India by four doctors with a total of 1,445 cases. Differences that resulted in conflicting outcomes (indication in one, contraindication in the other) were examined for possible causes. Results There was only a single outcome in the updated LMHI database that conflicted with the previous dataset, and this could have been due to statistical variation. The Indian data contained many cases, from few doctors, while the LMHI database had few cases per doctor, but many doctors. The overlap between the projects (individual cases entered in both) was between zero and 22%. In 72 comparisons we found six (8.3%) conflicting outcomes. Possible causes were statistical error due to small numbers of cases and/or observers, confirmation bias, and keynote prescribing if this resulted in symptoms being inadequately checked. Conclusion There was little conflict between the outcomes of the two versions of one project and between the two different PFR projects. Differences could mostly be explained by causes that can be managed. This consistency should primarily be interpreted as showing a strong overall consensus between homeopathic practitioners worldwide, but with variation of consensus between small groups of practitioners. pubtype: Academic Journal doctype: research tables/charts Journal Article ougenre: Article language: English refInfo: holdings: @attributes: islocal: N |
|---|